GlaxoSmithKline: Tetanus trials
The registry lists 106 Tetanus studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 62 have results posted.
Phase 2 16Phase 3 60Phase 4 22No phase 8(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and SafetyCompletedNCT00263692Phase 2
- Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.CompletedNCT00263679Phase 3
- Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsCompletedNCT00197275Phase 3
- Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 MthsCompletedNCT00158808Phase 2
- Post-marketing Safety Study of GSK Biological's Pediarix™ VaccineCompletedNCT00146835
- A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td VaccineCompletedNCT00109330Phase 3